# ClinicalTrials.gov record NCT01524770

> PeptideScanner retained ClinicalTrials.gov record NCT01524770 at 2026-07-30T21:54:46.539Z. Its registry update date was 2014-10-22, and PeptideScanner's reviewed identity mapping was dulaglutide.

- Evidence object: `story:clinicaltrials-gov-nct01524770-dulaglutide:v1`
- Evidence domain: Clinical trials
- Date in source: 2014-10-22
- Source checked: 2026-07-30
- Published by PeptideScanner: 2026-08-09
- Story landing page: https://peptidescanner.com/stories/clinicaltrials-gov-nct01524770-dulaglutide/
- JSON record: https://peptidescanner.com/evidence/v1/objects/clinicaltrials-gov-nct01524770-dulaglutide-v1.json
- Content SHA-256: `c6906486dca708847ee9ed78298233b538febcacec63c2e34d6b2d873c597663`

## Claims and source pins

### Headline

ClinicalTrials.gov record NCT01524770 ([`ctg-observation-nct01524770-2014-10-22-f53b7389ba05`](#source-ctg-observation-nct01524770-2014-10-22-f53b7389ba05))

### Summary

PeptideScanner retained ClinicalTrials.gov record NCT01524770 at 2026-07-30T21:54:46.539Z. Its registry update date was 2014-10-22, and PeptideScanner's reviewed identity mapping was dulaglutide. ([`ctg-observation-nct01524770-2014-10-22-f53b7389ba05`](#source-ctg-observation-nct01524770-2014-10-22-f53b7389ba05))

### Paragraph 1

PeptideScanner retained ClinicalTrials.gov record NCT01524770 at 2026-07-30T21:54:46.539Z. Its registry update date was 2014-10-22, and PeptideScanner's reviewed identity mapping was dulaglutide. ([`ctg-observation-nct01524770-2014-10-22-f53b7389ba05`](#source-ctg-observation-nct01524770-2014-10-22-f53b7389ba05))

### Paragraph 2

This page reports a dated retained registry observation and does not assert the record's current status; registration is not evidence that an intervention is safe or effective. ([`ctg-observation-nct01524770-2014-10-22-f53b7389ba05`](#source-ctg-observation-nct01524770-2014-10-22-f53b7389ba05))

## Sources

<a id="source-ctg-observation-nct01524770-2014-10-22-f53b7389ba05"></a>
- **ClinicalTrials.gov record NCT01524770 · retained source version 2014-10-22:f53b7389ba059778770d18cea2d6b5da820eaa8e95e2a8a4c19cc88585321e57** — ClinicalTrials.gov; class A. [Open source](https://clinicaltrials.gov/study/NCT01524770) (`ctg-observation-nct01524770-2014-10-22-f53b7389ba05`)

## Correction lineage

No correction is recorded for this version.

## Reporting boundaries and unknowns

PeptideScanner reports the cited trial-registry entry and its status at observation. Registration or completion does not establish safety, effectiveness, or regulatory approval.

- Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.
- This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.
- This object does not determine safety, efficacy, causality, or suitability for any person.

Methodology: https://peptidescanner.com/methodology/
Medical disclaimer: https://peptidescanner.com/medical-disclaimer/

## Suggested citation

PeptideScanner. "ClinicalTrials.gov record NCT01524770." Version 1, published 2026-08-09. https://peptidescanner.com/evidence/v1/objects/clinicaltrials-gov-nct01524770-dulaglutide-v1.json SHA-256: c6906486dca708847ee9ed78298233b538febcacec63c2e34d6b2d873c597663.